This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Oct 15;82(8):797.

doi: 10.1016/j.bcp.2011.05.002. Epub 2011 May 12.

Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science--Editorial Comments

Diana Donnelly-Roberts, Daniel Bertrand, Murali Gopalakrishnan

PMID: 21600889
DOI: 10.1016/j.bcp.2011.05.002

Editorial

Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science--Editorial Comments

Diana Donnelly-Roberts et al. Biochem Pharmacol. 2011.

. 2011 Oct 15;82(8):797.

doi: 10.1016/j.bcp.2011.05.002. Epub 2011 May 12.

Authors

Diana Donnelly-Roberts, Daniel Bertrand, Murali Gopalakrishnan

PMID: 21600889
DOI: 10.1016/j.bcp.2011.05.002

No abstract available

PubMed Disclaimer

Similar articles

Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science--editorial perspective.
Bertrand D, Gopalakrishnan M, Donnelly-Roberts D. Bertrand D, et al. Biochem Pharmacol. 2009 Oct 1;78(7):657. doi: 10.1016/j.bcp.2009.06.101. Epub 2009 Jul 1. Biochem Pharmacol. 2009. PMID: 19576180 No abstract available.
Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science - editorial comments.
Gopalakrishnan M, Bertrand D, Williams M. Gopalakrishnan M, et al. Biochem Pharmacol. 2007 Oct 15;74(8):1091. doi: 10.1016/j.bcp.2007.09.007. Biochem Pharmacol. 2007. PMID: 17889037 No abstract available.
Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science--editorial comments.
Dani JA, Donnelly-Roberts D, Bertrand D. Dani JA, et al. Biochem Pharmacol. 2013 Oct 15;86(8):1041. doi: 10.1016/j.bcp.2013.05.002. Epub 2013 May 14. Biochem Pharmacol. 2013. PMID: 23684691 No abstract available.
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
Hogg RC, Bertrand D. Hogg RC, et al. Biochem Pharmacol. 2007 Feb 15;73(4):459-68. doi: 10.1016/j.bcp.2006.08.010. Epub 2006 Sep 18. Biochem Pharmacol. 2007. PMID: 16979139 Review.
Brain nicotinic receptors as emerging targets for drug addiction: neurobiology to translational research.
Rahman S. Rahman S. Prog Mol Biol Transl Sci. 2011;98:349-65. doi: 10.1016/B978-0-12-385506-0.00008-9. Prog Mol Biol Transl Sci. 2011. PMID: 21199776 Review.

See all similar articles

Cited by

Desensitization mechanism in prokaryotic ligand-gated ion channel.
Velisetty P, Chakrapani S. Velisetty P, et al. J Biol Chem. 2012 May 25;287(22):18467-77. doi: 10.1074/jbc.M112.348045. Epub 2012 Apr 3. J Biol Chem. 2012. PMID: 22474322 Free PMC article.
Conformational transitions underlying pore opening and desensitization in membrane-embedded Gloeobacter violaceus ligand-gated ion channel (GLIC).
Velisetty P, Chalamalasetti SV, Chakrapani S. Velisetty P, et al. J Biol Chem. 2012 Oct 26;287(44):36864-72. doi: 10.1074/jbc.M112.401067. Epub 2012 Sep 13. J Biol Chem. 2012. PMID: 22977232 Free PMC article.
Crystal structure and dynamics of a lipid-induced potential desensitized-state of a pentameric ligand-gated channel.
Basak S, Schmandt N, Gicheru Y, Chakrapani S. Basak S, et al. Elife. 2017 Mar 6;6:e23886. doi: 10.7554/eLife.23886. Elife. 2017. PMID: 28262093 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science